Hypertriglyceridemic waist: An alternative to the metabolic syndrome Results of the IMAP Study (multidisciplinary intervention in primary care)

International Journal of Obesity

Volumn 35, Issue 2, 2011, Pages 292-299

  Gomez Huelgas, R ^a   Bernal Lopez M R ^b   Villalobos, A ^a   Mancera Romero, J ^c   Baca Osorio, A J ^c   Jansen, S ^a   Guijarro, R ^a   Salgado, F ^a   Tinahones, F J ^b   Serrano Rios M ^d  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c Health Center Ciudad Jardin   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

abdominal obesity; cardiometabolic risk; epidemiological; hypertrigliceridemic waist

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIET RESTRICTION; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDENTARY LIFESTYLE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTORS; SPAIN; TRIGLYCERIDES; URBAN HEALTH; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 79951678770     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.127     Document Type: Article

References (33)

1. Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E et al. Abdominal obesity and the metabolic syndrome: contri-bution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039-1049.
2. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C et al. Postprandial triglyceride response in visceral obesity in men. Diabetes 1998; 47: 953-960. (Pubitemid 28255671)
3. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-468. (Pubitemid 24096208)
4. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 2003; 77: 379-384. (Pubitemid 36133380)
5. Wang J. Waist circumference: a simple, inexpensive, and reliable tool that should be included as part of physical examinations in the doctor's office. Am J Clin Nutr 2003; 78: 902-903.
6. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004; 53: 1195-1200. (Pubitemid 38569003)
7. Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ et al. Critical evaluation of Adult Treatment Panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 2004; 27: 978-983. (Pubitemid 38420225)
8. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-2094. (Pubitemid 38970759)
9. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio heart study. Diabetes Care 2002; 25: 1177-1184. (Pubitemid 41071169)
10. Tankó LB, Bruun JM, Alexandersen P, Bagger YZ, Richelsen B, Christiansen C et al. Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation 2004; 110: 2246-2252. (Pubitemid 39372509)
11. Kahn HS, Valdez R. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am J Clin Nutr 2003; 78: 928-934. (Pubitemid 39663468)
12. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, For the Conference Participants. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433-438. (Pubitemid 38133916)
13. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome\a new worldwide definition. Lancet 2005; 366: 1059-1062. (Pubitemid 41338752)
14. The International Expert Committee. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 2009; 32: 1-8.
15. World Health Organization. Obesity: Preventing and Managing the Global Epidemic:Report on a WHO Consultation (WHO Technical Report Series 894). World Health Organization: Geneva, Switzerland, 2000.
16. Lemieux I, Alméras N, Mauriége P, Blanchet C, Dewailly E, Bergeron J et al. Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 2002; 18: 725-732. (Pubitemid 34873842)
17. LaMonte MJ, Ainsworth BE, DuBose KD, Grandjean PW, Davis PG, Yanowitz FG et al. The hypertriglyceridemic waist phenotype among women. Atherosclerosis 2003; 171: 123-130. (Pubitemid 37464637)
18. Bos G, Dekker JM, Heine RJ. Non-HDL cholesterol contributes to the 'hypertriglyceridemic waist' as a cardiovascular risk factor. The Hoorn Study. Diabetes Care 2004; 27: 283-284. (Pubitemid 38196755)
19. Solati M, Ghanbarian A, Rahmani M, Sarbazi N, Allahverdian S, Azizi F. Cardiovascular risk factors in males with hypertriglycemic waist (Tehran Lipid and Glucose Study). Int J Obes Relat Metab Disord 2004; 28: 706-709. (Pubitemid 38580980)
20. Tankó LB, Bagger YZ, Qin G, Alexandersen P, Larsen PJ, Christiansen C. Enlarged waist combined with elevated triglyce-rides is a strong predictor ofaccelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005; 111: 1883-1890. (Pubitemid 40570207)
21. Czernichow S, Bruckert E, Bertrais S, Galan P, Hercberg S, Oppert JM. Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men. Int J Obes (Lond) 2007; 31: 791-796. (Pubitemid 46663815)
22. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184. (Pubitemid 30451774)
23. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study. Circulation 1997; 95: 69-75. (Pubitemid 27029945)
24. St-Pierre J, Lemieux I, Perron P, Brisson D, Santuré M, Vohl MC et al. Relation of the 'hypertriglyceridemic waist' phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol 2007; 99: 369-373. (Pubitemid 46157216)
25. Onat A, Ayhan E, Hergenc G, Can G, Barlan MM. Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure. Metabolism 2009; 58: 963-970.
26. Lamarche B, Tchernof A, Mauriége P, Cantin B, Dagenais GR, Lupien PJ et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-1961. (Pubitemid 28298273)
27. Blackburn P, Lamarche B, Couillard C, Pascot A, Bergeron N, Prud'homme D et al. Postprandial hyperlipidemia: another correlate of the 'hypertriglyceridemic waist' phenotype in men. Atherosclerosis 2003; 171: 327-336. (Pubitemid 37486086)
28. St-Pierre J, Lemieux I, Vohl MC, Perron P, Tremblay G, Despres JP et al. Contribution of abdominal obesity and hypertriglyceride-mia to impaired fasting glucose and coronary artery disease. Am J Cardiol 2002; 90: 15-18. (Pubitemid 34671195)
29. Sam S, Haffner S, Davidson MH, D Agostino RB, Feinstein S, Kondos G et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care 2009; 32: 1916-1920.
30. Gazi IF, Filippatos TD, Tsimihodimos V, Saougos VG, Liberopoulos EN, Mikhailidis DP et al. The hypertriglyceridemic waist pheno-type is a predictor of elevated levels of small, dense LDL cholesterol. Lipids 2006; 41: 647-654. (Pubitemid 44547679)
31. World Health Organization. WHO Statistical Information System (WHOSIS). [Consulted in August 2009]. http://www3.who.int/whosis/.
32. Instituto Nacional de Estad́istica. INEbase [consulted in August 2009]. Available at: http://www.ine.es/inebase/.
33. Basterra-Gortari FJ, Bes-Rastrollo M, Segúi-Gómez M, Forga L, Alfredo-Martínez J, Mart́inez-González MA. Tendencias de la obesidad, diabetes mellitus, hipertensión e hipercolesterolemia en España (1997-2003). Med Clin (Barc) 2007; 129: 405-408.